|Bid||0.00 x 0|
|Ask||0.00 x 0|
|Day's range||16.00 - 18.23|
|52-week range||5.85 - 19.31|
|Beta (5Y monthly)||1.22|
|PE ratio (TTM)||N/A|
|Forward dividend & yield||N/A (N/A)|
|Ex-dividend date||27 Mar 2020|
|1y target est||N/A|
Yahoo Finance's Anjalee Khemlani breaks down the new deal the U.S. and sole monkeypox vaccine maker have reached to speed up vaccine distribution.
The U.S. government asks Bavarian Nordic, the sole manufacturer of a monkeypox vaccine, to find new partners.
(Bloomberg) -- The Biden administration is aiming to ramp up supplies of scarce monkeypox vaccine by clearing the way for a deal between manufacturer Bavarian Nordic A/S and a Michigan-based company to finish packaging millions of doses in the US.Most Read from BloombergApple Targets Sept. 7 for iPhone 14 Launch in Flurry of New DevicesXi and Putin to Attend G-20 Summit in Indonesia, Jokowi SaysCovid’s Harmful Effects on the Brain Reverberate Years LaterBiden's Next Grand Bargain Could Retire Tr